Loading...
Disease burden of food-related pathogens in the Netherlands, 2023
Citations
Altmetric:
Series / Report no.
Open Access
Type
Report
Language
en
Date
2025-01-17
Research Projects
Organizational Units
Journal Issue
Title
Disease burden of food-related pathogens in the Netherlands, 2023
Translated Title
Ziektelast van voedseloverdraagbare ziekteverwekkers in Nederland in 2023
Published in
Abstract
Het RIVM brengt elk jaar in kaart hoeveel jaren mensen een slechte gezondheid hebben of eerder overlijden (ziektelast) in Nederland door een infectie van de maag of darm. Het heeft hiervoor naar 14 ziekteverwekkers gekeken die deze infecties kunnen veroorzaken. Mensen kunnen hiermee besmet worden via voedsel, dieren, andere mensen of het milieu. In 2023 was de ziektelast van deze 14 ziekteverwekkers hoger dan in de drie jaren ervoor en hetzelfde als in 2019, het laatste jaar voor de coronapandemie. De ziektelast wordt met een internationale maat aangegeven: DALY's (Disability Adjusted Life Years). Het verschilt per ziekteverwekker in welke mate ze via de verschillende routes mensen besmetten. In 2023 was het totale aantal DALY's voor de Nederlandse bevolking als gevolg van deze 14 ziekteverwekkers 11.000 DALY's. Dat was hoger dan in 2022 (10.000 DALY's), 2021 (9.100 DALY's) en 2020 (7.300 DALY's). Het deel van de ziektelast dat via voeding is veroorzaakt, is in 2023 geschat op 4.700 DALY's. Dit was iets hoger dan in 2022 (4.300 DALY's), 2021 (4.200 DALY's) en 2020 (3.600 DALY's) en zelfs iets hoger dan in 2019 (4.600 DALY's). De totale kosten van de ziektelast van de ziekteverwekkers zijn geschat op 538 miljoen euro in 2023. Dat is veel hoger dan in 2022 (496 miljoen euro), 2021 (411 miljoen euro) en 2020 (328 miljoen euro), en zelfs hoger dan in 2019 (497 miljoen euro). De geschatte kosten gaan over de directe medische kosten, zoals in ziekenhuizen, en de kosten die de patiënten en families maken, zoals reiskosten. Hieronder vallen ook de kosten die in andere sectoren worden gemaakt, bijvoorbeeld door ziekteverzuim. De kosten als gevolg van maag-darminfecties door deze ziekteverwekkers via voeding waren in 2023 met 217 miljoen euro hoger dan in 2022 (209 miljoen euro ). Ook waren ze hoger dan in 2021 (197 miljoen euro) en 2020 (179 miljoen euro), en zelfs iets hoger dan in 2019 (214 miljoen euro). Het ministerie van VWS heeft de opdracht voor dit onderzoek gegeven. De resultaten geven beleidsmakers handvatten om meer zicht te krijgen op de ziektelast en de manieren waarop mensen met de ziekteverwekkers in contact komen. Ook geeft het een beeld hoe de ziektelast van voedselinfecties en de kosten ervan zich door de jaren heen ontwikkelen.
Each year, RIVM examines how many people become ill or die from gastrointestinal infections in the Netherlands. The study focuses on 14 pathogens known to cause these infections, which can be transmitted through food, human-to-human contact, animals or environmental sources. The disease burden associated with these 14 pathogens in 2023 was higher than in 2022, 2021, and 2020, reaching levels comparable to 2019, the last pre-COVID-19 year. The disease burden is expressed in Disability Adjusted Life Years (DALYs), an international metric used to quantify the number of healthy years of life lost due to disability or premature death. In 2023, the total number of DALYs resulting from these 14 pathogens was 11,000 DALYs, an increase from 10,000 DALYs in 2022, 9,100 DALYs in 2021, and 7,300 DALYs in 2020. The number of DALYs in 2023 was the same as in 2019 (11,000 DALYs). The fraction of the 2023 disease burden attributable to foodborne transmission was estimated at 4,700 DALYs. This was higher than in 2022 (4,300 DALYs), 2021 (4,200 DALYs), and 2020 (3,600 DALYs), and slightly higher than in 2019 (4,600 DALYs). The total costs associated with the disease burden from the 14 pathogens in 2023 have been estimated at 538 million euros. This was higher than the costs for 2022 (496 million euros), 2021 (411 million euros), 2020 (328 million euros) and 2019 (497 million euros). The estimated costs include direct medical costs, such as hospitalizations, as well as indirect costs incurred by patients and families, such as travel expenses. Additionally, the costs include the losses incurred in other sectors, such as those from absenteeism. The costs due to gastrointestinal infections caused by foodborne transmission in 2023 (217 million euros) were also higher than in 2022 (209 million euros), 2021 (197 million euros) and 2020 (179 million euros) and slightly higher than in 2019 (214 million euros). This study was commissioned by the Ministry of Health, Welfare and Sport. The results provide policy-makers with insights into the burden of disease of food-related pathogens. This study also allows monitoring of possible trends in time of the burden of disease caused by foodborne infections, as well as of the associated costs
Each year, RIVM examines how many people become ill or die from gastrointestinal infections in the Netherlands. The study focuses on 14 pathogens known to cause these infections, which can be transmitted through food, human-to-human contact, animals or environmental sources. The disease burden associated with these 14 pathogens in 2023 was higher than in 2022, 2021, and 2020, reaching levels comparable to 2019, the last pre-COVID-19 year. The disease burden is expressed in Disability Adjusted Life Years (DALYs), an international metric used to quantify the number of healthy years of life lost due to disability or premature death. In 2023, the total number of DALYs resulting from these 14 pathogens was 11,000 DALYs, an increase from 10,000 DALYs in 2022, 9,100 DALYs in 2021, and 7,300 DALYs in 2020. The number of DALYs in 2023 was the same as in 2019 (11,000 DALYs). The fraction of the 2023 disease burden attributable to foodborne transmission was estimated at 4,700 DALYs. This was higher than in 2022 (4,300 DALYs), 2021 (4,200 DALYs), and 2020 (3,600 DALYs), and slightly higher than in 2019 (4,600 DALYs). The total costs associated with the disease burden from the 14 pathogens in 2023 have been estimated at 538 million euros. This was higher than the costs for 2022 (496 million euros), 2021 (411 million euros), 2020 (328 million euros) and 2019 (497 million euros). The estimated costs include direct medical costs, such as hospitalizations, as well as indirect costs incurred by patients and families, such as travel expenses. Additionally, the costs include the losses incurred in other sectors, such as those from absenteeism. The costs due to gastrointestinal infections caused by foodborne transmission in 2023 (217 million euros) were also higher than in 2022 (209 million euros), 2021 (197 million euros) and 2020 (179 million euros) and slightly higher than in 2019 (214 million euros). This study was commissioned by the Ministry of Health, Welfare and Sport. The results provide policy-makers with insights into the burden of disease of food-related pathogens. This study also allows monitoring of possible trends in time of the burden of disease caused by foodborne infections, as well as of the associated costs
Description
Publisher
Rijksinstituut voor Volksgezondheid en Milieu RIVM